Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.

By July 12, 2022DeFi

–Kala Will Receive $60 Million in Upfront Payment; Eligible to Receive Additional Sales-Based Milestone Payments– –Kala Will Focus Resources on Phase 2/3 Trial of KPI-012 for Orphan Disease Persistent […]

All Today's Crypto News In One Place